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ABSTRACT We have inactivated the endogenous apolipo-
protein E (apoE) gene by using gene targeting in mouse
embryonic stem (ES) cells. Two targeting plasmids were used,
pJPB63 and pNMC109, both containing a neomycin-resistance
gene that replaces a part of the apoE gene and disrupts its
structure. ES cell colonies targeted after electroporation with
plasmid pJPB63 were identified by the polymerase chain
reaction (PCR) followed by genomic Southern analysis. Of 648
G418-resistant colonies analyzed, 9 gave a positive signal after
PCR amplification, and 5 of them were confirmed as targeted
by Southern blot analysis. The second plasmid, pNMC109,
contains the negatively selectable thymidine kinase gene in
addition to the neomycin-resistance gene. After electroporation
with this plasmid, 177 colonies resistant both to G418 and
ganciclovir were analyzed; 39 contained a disrupted apoE gene
as determined by Southern blotting. Chimeric mice were
generated by blastocyst injection with 6 of the targeted lines.
One of the lines gave strong chimeras, three of which trans-
mitted the disrupted apoE gene to their progeny. Mice ho-
mozygous for the disrupted gene were produced from the
heterozygotes; they appear healthy, even though they have no
apolipoprotein E in their plasma.
The etiology of atherosclerosis is complex. Its development
is affected by many different genes, including those related to
lipid metabolisms, and is greatly influenced by environmental
factors (1, 2). In addition, because the disease can be repro-
duced only in a living animal, there are no adequate in vitro
systems available. For studying this type of complex multi-
factorial disease, gene targeting in mouse embryonic stem
cells (ES cells) provides a unique tool [for reviews see
Capecchi (3) and Smithies (4)]. It allows the generation of
animals with changes in specific genes, and thence the study
of the effects of these changes on the physiological state of
the animals. We have, therefore, started to make specific
alterations in lipid metabolism related genes of otherwise
normal mice by homologous recombination in ES cells as
another approach to dissecting some of the molecular details
of atherogenesis.
Apolipoprotein E (apoE) is a constituent of very low
density lipoprotein (VLDL) synthesized by the liver (5), and
of a subclass of high density lipoproteins (HDLs) involved in
cholesterol transport among cells (6). apoE mediates high-
affinity binding of apoE-containing lipoprotein particles to
the low density lipoprotein (LDL) receptor and is thus
responsible for the cellular uptake of these particles (7). apoE
is also a major protein constituent of remnant particles of
intestinally synthesized chylomicrons (8). After transport of
dietary cholesterol and triglycerides, chylomicron remnants
are taken up by the liver by an apoE-dependent receptor-
mediated mechanism (9). In humans, a variant form of apoE
that is defective in binding to the LDL receptor is associated
with familial type III hyperlipoproteinemia, a disease char-
acterized by elevated plasma cholesterol and premature
coronary heart disease (10, 11). In addition to its involvement
in cholesterol and lipid metabolism, apoE has been impli-
cated in regulation of the immune response (12), in nerve
regeneration (13, 14), and in muscle differentiation (15, 16).
In the present paper, we describe the results of experi-
ments that have allowed us to inactivate the mouse apoE
locus by homologous recombination. Animals homozygous
for the modified apoEgene are devoid ofapoE protein in their
sera. Further studies of these animals are expected to lead to
a better understanding ofthe role ofapoE in lipid metabolism,
atherogenesis, nerve injury, and other biological phenomena.
MATERIALS AND METHODS
Cloning of the apoE Gene. Mouse genomic DNA, isolated
from STO cells (17) and fully digested with EcoRI, was used
to make a library in A phage Charon 32 (18). The library was
screened with an apoE-specific probe (a Sac I/Bgl II frag-
ment) isolated from a mouse apoE cDNA clone (19), which
was kindly provided by A. J. Lusis (University of California,
Los Angeles). From one of the strongly hybridizing phage
clones obtained in this screening, a 7.8-kilobase (kb) EcoRI
fragment was isolated. Comparison of the restriction map of
this fragment with the nucleotide sequence of the mouse
apoE gene (20) showed that it contained the complete apoE
gene in addition to 5.7 kb of its upstream sequence.
Cell Culture and Electroporation. An ES cell line,
E14TG2a, obtained from Martin Hooper (21), was used for all
experiments. Cells were maintained in Dulbecco's modified
Eagle's medium (DMEM), supplemented with 15% fetal
bovine serum, 0.1 mM 2-mercaptoethanol, and 2 mM gluta-
mine (ES medium). Penicillin (100 international units/ml) and
streptomycin (100 ,g/ml) were used in some experiments.
ES cells were maintained on embryonic fibroblast feeder
layers prepared as previously described (22).
Cells were electroporated essentially as described by Reid
et al. (23), using linearized DNA at a final concentration of
2-5 nM. Electroporated cells were plated at a density of 1-2
x 101 cells per 10-cm plate. Twenty-four hours after elec-
troporation, the ES medium was replaced with medium
containing 150-200 ,ug of G418 per ml with or without 2 ,M
ganciclovir (Ganc; gift from Syntex, Palo Alto, CA). G418
selects for neomycin phosphotransferase (neo) and Ganc
selects against herpes simplex thymidine kinase (TK) expres-
sion.
Abbreviations: apoE, apolipoprotein E; HDL, high density lipopro-
tein; LDL, low density lipoprotein; VLDL, very low density lipo-
protein; ES cells, embryonic stem cells; neo, neomycin phospho-
transferase; TK, thymidine kinase; Ganc, ganciclovir.
*Present address: Department of Veterinary Anatomy and Public
Health, Texas A&M University, College Station, TX 77840-4458.
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Screening for Homologous Recombinants. ES cells carrying
an apoE gene disrupted by homologous recombination were
identified by polymerase chain reaction (PCR) and/or by
genomic Southern blotting. Briefly, 10-14 days after electro-
poration and selection by G418, individual colonies were
picked and divided into two parts. One portion was used for
further growth and the other was combined with portions
from 3-5 other colonies to form pools of 4-6 colonies per
pool. DNA was isolated from pooled cells and subjected to
PCR as described (23, 24), except that 0.5 jig of each primer
and 1.0 unit of Taq DNA polymerase were used in the
reaction, and that dimethyl sulfoxide was omitted. The
mixture was amplified for 55 cycles with 60 sec of denatur-
ation at 920C followed by 10 min of annealing and extension
at 650C. The primers used were apoE-specific, 5'-
TGTCTTCCACTATTGGCTCG-3'; and neo-specific, 5'-
TGGCGGACCGCTATCAGGAC-3'. After PCR, samples
were electrophoresed in 1.5% agarose and transferred to
nylon membranes (Hybond, Amersham). Filters were hy-
bridized with the 32P-labeled apoE-specific probe described
above to detect a 1.2-kb diagnostic band (see Fig. 1).
When plasmid pNMC109 was employed as the targeting
plasmid, Southern blot analysis was used to screen for
homologous recombinants. Individual colonies were ex-
panded and genomic DNA was prepared, most conveniently
by the "salting out" procedure of Miller et al. (25).
Generation of Germ-Line Chimeras. Chimeras were gener-
ated as previously described by Koller et al. (26). Animals
classified as chimeric by coat color were mated to strain 129
and/or C57BL/6J mice. DNA samples were isolated from
tails of ES cell-derived animals by the salting out procedure
and were analyzed for the presence of a disrupted apoE gene
by genomic Southern blotting.
Double Immunodiffusion Test. Double immunodiffusion
precipitation (27) on glass slides was carried out for apoE
detection in 1.0% agarose in phosphate-buffered saline (PBS)
containing 3% (wt/vol) polyethylene glycol (Mr = 8000).
Rabbit antiserum to rat apoE was kindly supplied by John
Taylor (University of California, San Francisco). Blood
samples were collected in EDTA-coated capillaries from the
tails of animals between 2 weeks and 3 weeks of age, and
plasma was isolated by centrifugation. Plasma (5-8 ,l) in the
peripheral wells was used with 8 Al of antiserum in the central
well. The slides were incubated in a wet chamber for 16 hr at
37°C, washed in PBS for 2 days, and stained with Coomassie
brilliant blue G250.
RESULTS
Construction of Targeting Plasmids. Two different target-











fragment. Plasmid pJPB63 (Fig. lb) was constructed by
removing a 1.1-kb Sac I fragment containing part of intron 1
through part of exon 3 and replacing it with the neo gene
driven by a TK promoter and a mutated polyoma enhancer
[pMCneopolyA (28)]. In addition, a 400-base-pair (bp) BstEII
fragment corresponding to the 3' end ofexon 4 and 3' flanking
region was deleted to facilitate the choice of a PCR primer
sequence unique to the target locus. The plasmid contains 4.9
kb of uninterrupted sequence in the 5' region and 700 bp in
the 3' region; prior to electroporation it was digested with Nsi
I and Cla I.
The second plasmid, pNMC109 (Fig. 2b), was designed so
as to be able to use positive-negative selection as described
by Mansour et al. (29). pNMC109 was constructed from the
7.8-kb EcoRI fragment by removing an Xho I/BamHI frag-
ment containing part of exon 3 and part of intron 3 and
replacing it by the neo gene. In addition, a copy of the herpes
simplex virus TK gene was placed at the 3' end of the
construct. Both of these selectable marker genes are inserted
in the same transcriptional orientation as the apoE gene. The
plasmid contained 6.4 and 1.2 kb of uninterrupted sequences
in the 5' and 3' region, respectively. Prior to electroporation,
the plasmid was linearized by digestion at a Not I site (not
shown) that occurs in the plasmid vector 5' to the end of the
apoE insert.
Targeting with pJPB63. Four electroporations were carried
out with plasmid pJPB63. The number of cells treated ranged
from 2 x 107 to 8 x 107 (Table 1). For the first three
electroporations, PCR analysis was carried out on pools of
4-6 colonies per pool. Six of 128 pools analyzed gave a
positive PCR signal as judged by amplification of the 1.2-kb
fragment diagnostic of targeting. From these 6 pools, four
individual PCR-positive clones were identified. For the
fourth electroporation ofthe series, PCR analysis was carried
out on individual colonies instead of on pools. From 72
colonies analyzed, 3 were PCR positive, although two of
them were lost due to contamination prior to genomic anal-
ysis (Table 1).
To confirm the occurrence of the targeted disruption of the
apoE gene, PCR-positive clones were expanded and DNA
isolated from them was digested with EcoRI, Nco I, orBgl II.
Introduction of the neo gene in the planned manner creates
a new EcoRI site in the locus, and a 2.4-kb fragment is
thereby generated. An undisrupted apoE gene generates a
7.8-kb fragment. Fig. ld illustrates this distinction, with the
parental cell line (lanes P) giving only the 7.8-kb fragment and
a targeted cell line (lanes T) giving both the 7.8-kb fragment
and the new 2.4-kb fragment, thus confirming the presence of
one normal and one disrupted apoE gene. Similarly, Nco I
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FIG. 1. Targeting of the mouse apoE gene by using pJPB63. (a) Normal mouse apoE locus. (b) Targeting Nsi I/Cla I fragment of pJPB63.
(c) The apoE locus after homologous recombination, indicated by the Xs between a and b. Black boxes indicate apoE exons and the open box
indicates a neo gene. Small arrows indicate the locations of PCR primers and large dashed arrows indicate the expected PCR fragment. The
apoE-specific probe is indicated by a hatched box. E, EcoRI; N, Nco I; B, Bgl II; C, Cla I; Ns, Nsi I. (d) Southern blot analysis of genomic
DNA from parental (P) and targeted (T) cell lines. Fragment sizes sizes are in kb.
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FIG. 2. Targeting of the apoE gene by using pNMC109. (a) Normal mouse apoE locus. (b) Linearized targeting plasmid pNMC109; the TK
gene and plasmid sequences at the 3' end of the targeting fragment are not to scale. (c) The apoE locus after homologous recombination. E,
EcoRI; H, HindIII; X, Xmn I. The diagnostic HindIII fragments used for screening by Southern blotting are shown by dashed lines with their
sizes. (d) Southern blot analysis of HindIII digests of genomic DNA from fast-growing colonies. (e) Southern blot analysis of DNA from
slow-growing colonies. In d and e, arrowheads indicate 7.5-kb bands and asterisks indicate targeted cells.
and Bgl II digestions of the targeted line showed 1.6- and
3.0-kb fragments, respectively, indicative of a disrupted
apoE gene, in addition to the 7.0- and 1.8-kb bands indicative
of an undisrupted apoE gene, respectively.
When the blot shown in Fig. ld was rehybridized to a probe
specific for the neo gene, only bands predicted from the
structure in Fig. ic were detected, showing that no insertions
ofthe targeting plasmid had occurred at nonhomologous sites
(results not shown). Thus all three enzyme digests confirm
the PCR results by demonstrating that the cell lines analyzed
carry a disrupted apoE gene.
The combined targeting frequency for all electroporations
was 0.77% (5/648) of the G418-resistant colonies, with a
range of 0.5% (1/192) to 1.3% (1/72) (Table 1). The overall
targeting frequency at the mouse apoE locus when pJPB63
was used was 2.6 in 107 treated cells.
Targeting with pNMC109. Five electroporations were car-
ried out as summarized in Table 2. A combined total of 1132
colonies doubly resistant to G418 and Ganc were obtained,
and 177 of these colonies were expanded. As illustrated in
Fig. 2, if homologous recombination takes place between the
endogenous apoE locus and the plasmid pNMC109, the size
of the HindIII fragment hybridizing to the apoE probe
increases from 6.5 to 7.5 kb. Thus the presence of a 7.5-kb
band in the Southern blot analysis was used to diagnose
homologous recombination (Fig. 2 d and e).
During this screening, we noted that a higher proportion of
slow-growing colonies (picked after 12 days of double selec-
tion) were targeted compared with fast-growing colonies
(picked after 10 days of selection). As illustrated in Fig. 2 dand
e, only 1 of 15 fast-growing colonies was targeted (6.6%),
compared with 6 of 16 slow-growing colonies (37%). Alto-
gether, we identified 39 targeted colonies in 177 of the doubly
resistant colonies (acombined frequency of22%; Table 2). The
frequency in individual electroporations ranged from 8.3%
Table 1. Targeting the mouse apoE gene with pJPB63
No. of No. of PCR-
cells G418r pools positive Targeted
Exp. treated colonies analyzed* pools coloniest
1 2 x 107 420 36 (4) 2 1
2 4 x 107 660 32 (6) 1 1
3 8 x 107 3216 60 (4) 3 2
4 4 x 107 1808 72 (1) 3 1
All electroporations were carried out at 200,F and 300 V in ES cell
medium. G418r, G418-resistant.
*The number of colonies in each pool is in parentheses.
tThe number of colonies isolated and confimed by Southern blots.
(2/24) to 45.8% (11/24). The higher frequency obtained in the
fifth electroporation was partly because in this experiment we
analyzed only the slower-growing colonies. Excluding the last
electroporation, the overall targeting frequency with
pNMC109 was estimated to be one in 106 treated cells.
The existence ofthe desired modification ofthe apoE locus
in the isolated cell lines was confirmed by Southern blot
analysis of DNA digested with various enzymes. Of the 39
cell lines isolated in the pNMC109 experiments 37 showed a
simple pattern of two hybridizing bands of equal intensity,
one corresponding to the endogenous apoE locus and the
other to the modified locus (see, as an example, clone SZ-26
in lanes 2 of Fig. 3).
The two remaining clones, T-88 and T-89, showed a third,
strongly hybridizing fragment in each digest in addition to the
two bands indicative of a targeted cell (see, for example,
clone T-89 in lanes 3 of Fig. 3). Digests of the DNA from T-88
always gave patterns identical to those from T-89, and it is
likely that they are of identical origin (they were picked one
after the other from a single dish). The third hybridizing band
in T-89 DNA digested with Xmn I is 7.9 kb in length, is
approximately 4-5 times as intense as the other two bands,
and also hybridizes to plasmid vector DNA. Similarly, extra
bands of 12 and 4.3 kb were seen in Xba I and Kpn I digests,
respectively (see Fig. 3).
Analysis of T-89 DNA with several other restriction en-
zymes (Apa I, BamHI, HindIII, Not I, and Sac I) with both
the apoE probe and a plasmid vector probe failed to reveal
any bands, suggesting that the extra copies are integrated at
nonhomologous locations in the genome. These various
results are consistent with the explanation that four to five
Table 2. Homologous recombination at the apoE locus
with pNMC109
G418r +
No. of G418r + Gancr
cells G418r Gancr colonies Targeted
Exp. treated colonies* colonies analyzed colonies
1 4 x 107 690 218 24 2
2 8 x 107 2120 206 29 4
3 4 x 107 1245 412 21 3
4 2.5 x 107 400 120 79 19
5 4 x 107 480 176 24 11
Electroporation experiments 1-3 were carried out at 200 ,tF and
300 V in ES medium, and experiments 4 and 5 were carried out at 250
.LF and 350 V in PBS. G418r, G418-resistant; Gancr, Ganc-resistant.
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FIG. 3. Southern blot analysis of ES cells targeted with
pNMC109. Genomic DNA ofparental ES cells (lanes 1), SZ-26 (lanes
2), and T-89 (lanes 3) was digested with Xba I, Xmn I, or Kpn I.
identical copies of incoming plasmid have integrated in a
head-to-tail concatemeric orientation at the apoE locus. The
sizes offragments obtained with these digests suggest that the
incoming linear DNA lost about 1.6 kb of DNA prior to its
concatemerization.
Production of Chimeras and Transmission of the Modified
Gene. Six different targeted ES cell lines were tested for the
production of chimeras after injection into C57BL/6J blas-
tocysts; one (A13-D) had been targeted with the plasmid
pJPB63, the other five (T-76, T-84, T-89, SZ-38, and SZ-91)
with the pNMC109 plasmid. About 50 embryos were used to
test each line. All six generated chimeras-ranging from very
weak (less than 10% contribution ofES cells to coat color) for
chimeras obtained from cell line T-84 to very strong (greater
than 801%) for chimeras obtained with cell line T-89. In all, a
total of 95 embryos were injected with T-89 cells to obtain 6
male and 4 female chimeras with 60-100% ES cell contribu-
tion. Two males and one female were found to be germ-line
competent. [Germ-line transmission of the E14TG2a ES cell
genome through female chimera has previously been re-
ported by Koller et al. (30).] One male chimera, JH126.1,
transmitted the ES cell genome to 100%o of its offspring. A
Southern blot of tail DNA from his pups revealed that 14 of
30 pups (the expected Mendelian proportion) have inherited
the disrupted copy of the apoE gene (Fig. 4a).
(C57BL/6J x 129) F1 animals heterozygous for the dis-
rupted apoE gene are healthy at age 3 months and are
breeding normally. From two sets of heterozygous F1 mat-
a





ings, we have obtained litters of 8 and 6 pups to date. Three
of these 14 animals are homozygous for the modified apoE
locus (the expected Mendelian proportion), as identified by
Southern blot of their tail DNA (Fig. 4b). All appear healthy
at age 4-6 weeks.
Plasma was obtained from the offspring of a mating be-
tween heterozygotes, and the presence of apoE protein was
investigated by the Ouchterlony double immunodiffusion
method, using a rabbit antiserum to rat apoE. As Fig. 5
illustrates, plasma from the animal homozygous for the
modified apoE gene gave no detectable immunoprecipitate
with anti apoE antiserum, although precipitation is clearly
visible with plasma from animals heterozygous or homozy-
gous for the normal gene. The plasma level of apoE in
heterozygotes appears to be less than that in the normal
animal asjudged by the positions where the precipitates were
formed.
DISCUSSION
We have inactivated the apoE gene in mouse ES cells by
homologous recombination. Colonies targeted with plasmid
pJPB63 were identified by PCR and confirmed by genomic
Southern blotting. As shown in Table 1, four independently
targeted cell lines were isolated from seven PCR-positive
pools. This corresponds to a confirmed frequency of 1
targeting in 120 G418-resistant colonies (Table 1). This rela-
tively high frequency encouraged us to screen single colonies
by PCR in the fourth experiment. In this experiment, 3 out of
72 individually amplified colonies gave a positive PCR signal,
and one of these was confirmed to be targeted by Southern
blotting.
The overall frequency of finding targeted cells was con-
siderably improved when a plasmid containing a TK tail,
pNMC109, was used in conjunction with the positive-
negative protocol (29). The frequency ranged from 1/12 to
1/2 of the doubly selected cells (Table 2). The highest
frequency, obtained in the last electroporation, was probably
because only slower-growing (late-appearing) colonies were
analyzed in this experiment, following our observation that a
higher proportion of late-appearing colonies were targeted
compared with early-appearing colonies. A possible expla-
nation is that colonies are able to grow in G418 faster when
they have multiple copies of the neo gene inserted into their
genomes. This explanation is supported by our finding that
the early-appearing colonies tend to have extra hybridizing
bands, indicative of multiple integrations, in their Southern
blot analysis (Fig. 2d). This agrees with previous observa-
tions reported by Reid et al. (23) that targeted colonies rarely
have multiple inserts.
During our screening for cell lines targeted with pNMC109
we isolated two (probably not independent) cell lines con-
taining an additional restriction fragment indicating that the
plasmid had been integrated into the target apoE locus as a
+1+
o f 4b
FIG. 4. Transmission ofthe targeted apoE gene. (a) Southern blot
of HindIII digests of genomic DNA isolated from tails of agouti
offspring of JH126.1 mated with C57BL/6J females. (b) DNA from
pups of a cross between heterozygous F1 animals. The 6.5-kb bands
indicate transmission of the normal allele and the 7.5-kb bands
indicate transmission of the modified allele. The 2.8-kb band is
derived from the concatemeric insert in the T-89 cell line (see text).
-'-
FIG. 5. Double immunodiffusion test ofapoE expression. Plasma
of normal (+/+, 5 gl), heterozygous (+/-, 8 gl), and homozygous
(-on-, 8 () mice were placed in peripheral wells and 8 "I of rabbit
antiserum to rat apoE was placed in the central well.
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head-to-tail concatemer. Similar observations have been
made by Thomas and Capecchi (31) and Hasty et al. (32).
Mapping of the T-89 DNA shows that the TK gene in the
concatemer appears to be complete, although the cells are
resistant to Ganc. Presumably the TK gene was inactivated
prior to the integration, but the inactivation was not caused
by a gross deletion. Our best estimate is that there are four
or five tandem copies of the initially 13.6-kb pNMC109
plasmid, shortened by 1.6 kb from the ends, inserted into the
apoE locus in the T-89 cell line. The existence of these copies
does not materially affect the value of this cell line, which is
the one that to date has yielded chimeras able to transmit a
disrupted apoE gene to their progeny.
The animals that are heterozygous for the disrupted apoE
gene are apparently in good health at age 3 months. Two pairs
of heterozygotes have been mated, and to date we have
obtained 14 pups, of which 3 are homozygous and 8 are
heterozygous for the targeted disruption of the apoE gene.
All these animals are apparently healthy at age 4-6 weeks.
The disrupted gene is transmitted at a frequency that does not
differ significantly from that of the normal gene. A homozy-
gous animal is predicted, from its genotype, to be unable to
synthesize apoE. Immunodiffusion tests (Fig. 5) of plasma
from one of the homozygous animals confirm this expecta-
tion. Thus, judging at the level ofgenomic DNA structure and
at this level ofplasma apoE, we have succeeded in generating
mice that lack apoE expression.
The facts that homozygous animals have been born at the
expected frequency and that they appear to be healthy are
important. They demonstrate that lack of apoE is compatible
with normal development, and they also provide another tool
for studies of the phenotypic consequences of apoE defi-
ciency. Rare examples of apoE deficiencies have been re-
ported in humans (11, 33, 34), where they cause a form oftype
III hyperlipoproteinemia. In one case, the deficiency was the
consequence of a mutation in a splicing site in the apoE gene
that prevents normal mRNA processing (35). Considering the
importance of apoE protein in the binding of remnants of
chylomicron and VLDL to receptors, we expect that mice
without apoE will in due course show a phenotype similar to
type III hyperlipoproteinemia in humans, and they will
therefore have a recessively inherited predisposition to cor-
onary heart disease. One caveat is, however, required: mice
have substantially different relative lipoprotein levels from
humans, and they use HDL as a major cholesterol carrier
(36), while humans use LDL. Thus the immediate phenotype
of apoE deficiency may be different in mice from that in
humans. The progression of our animals and their responses
to dietary factors will be of considerable interest. In addition,
we expect that combining the deficiency of apoE in these
animals with defects in other lipid metabolism related gene
defects, arising spontaneously (37) or generated by gene
targeting, should help in dissecting genetic and environmen-
tal factors that can lead to coronary heart disease.
Mention should also be made of the putative importance of
apoE in the repair of injury in peripheral nerve tissue.
Following nerve injury, macrophages within the sciatic nerve
start to produce apoE, which is probably involved in the
removal of debris from damaged cells and in the stimulation
of regeneration of the peripheral nerve cells (13). It will be of
considerable interest to observe the responses of the apoE-
deficient mice to nerve injury.
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